CMV

COMMUNIQUÉS West-GlobeNewswire

Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
08/07/2025
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of [...]
AJA Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
08/07/2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer [...]
Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts
08/07/2025
GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016 ® [Vaccinia Immune Globulin Intravenous (Human)] ( [...]
Vireo Growth Inc. Completes Loan Refinancing and Upsize With a Bank Led Syndicate Arranged by CEO, John Mazarakis
08/07/2025
-- Company completes refinancing of all existing senior secured debt through a $120 million self-syndicated term loan with leading banks, at an interest rate of 8.3% -- -- Company also completes expansion of its [...]
Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock
08/07/2025
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today [...]
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
08/07/2025
Medium and high doses improved movement quality in up to 100% of the animals in a dose-dependent manner TORONTO and HAIFA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE [...]
Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
08/07/2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and [...]
Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
08/07/2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de [...]
BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025
08/07/2025
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 financial results [...]
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
08/07/2025
Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
08/07/2025
- SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Designation from the [...]
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
08/07/2025
ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
08/07/2025
PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a registered direct offering [...]
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025
08/07/2025
BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, after the market [...]
Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity
08/07/2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
New Fat Burner for Women Launched Over the Counter - PhenQ Medically Accredited Fat Burning Supplement
08/07/2025
Clinicians’ Choice Fat Burner for Women, PhenQ: Clinically Endorsed by 800 Healthcare Professionals Launched Over the Counter in the USA and Worldwide. New York City, NY, July 08, 2025 (GLOBE NEWSWIRE) -- Women [...]
Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare
08/07/2025
Transforming Healthcare Ltd Unveils the Healthcare Convergence Framework® AI/Robotics Self-Assessment Scorecard London, UK , July 08, 2025 (GLOBE NEWSWIRE) -- Transforming Healthcare Ltd, a leader in healthcare [...]
ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds
08/07/2025
WESTON, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with [...]
From Stem Cells to CAR-T: LivMedCell Expands Its Role in the Future of Medicine
08/07/2025
Photo: LivMedCell via FL Communications ISTANBUL, July 08, 2025 (GLOBE NEWSWIRE) -- LivMedCell has officially launched a groundbreaking research collaboration with the University of Pennsylvania’s Perelman School of [...]

Pages